Inspire Medical Systems, Inc. (INSP) stock
INSPNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 19/3060% below fair value
$55.10−1.18 (-2.10%)
Close on Nov 20, 2026Market cap $1.59BP/E 11.9Yield –
Inspire Medical Systems free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Inspire Medical Systems's free cash flow for the twelve months ending Jun 30, 2026 was $117.09M, up 37.7% year over year. For fiscal 2025 it was $78.48M, down 13.9% from the year before. The highest annual figure on record is $91.12M in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $78.48M | -13.9% |
| FY2024 | Dec 31, 2024 | $91.12M | +8798.7% |
| FY2023 | Dec 31, 2023 | $1.02M | -58.6% |
| FY2022 | Dec 31, 2022 | $2.47M | – |
| FY2021 | Dec 31, 2021 | -$24.79M | – |
| FY2020 | Dec 31, 2020 | -$55.50M | – |
| FY2019 | Dec 31, 2019 | -$35.59M | – |
| FY2018 | Dec 31, 2018 | -$18.94M | – |
| FY2017 | Dec 31, 2017 | -$16.20M | – |
| FY2016 | Dec 31, 2016 | -$18.26M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $14.07M | – |
| Q1 FY2026 | Mar 31, 2026 | $3.12M | – |
| Q4 FY2025 | Dec 31, 2025 | $41.81M | -32.7% |
| Q3 FY2025 | Sep 30, 2025 | $58.09M | +31.2% |
| Q2 FY2025 | Jun 30, 2025 | -$6.31M | – |
| Q1 FY2025 | Mar 31, 2025 | -$15.11M | – |
| Q4 FY2024 | Dec 31, 2024 | $62.15M | +573.1% |
| Q3 FY2024 | Sep 30, 2024 | $44.28M | – |
| Q2 FY2024 | Jun 30, 2024 | -$12.47M | -5362.0% |
| Q1 FY2024 | Mar 31, 2024 | -$2.84M | – |
| Q4 FY2023 | Dec 31, 2023 | $9.23M | -43.4% |
| Q3 FY2023 | Sep 30, 2023 | -$3.35M | -144.7% |
| Q2 FY2023 | Jun 30, 2023 | $237.00K | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.10M | – |
| Q4 FY2022 | Dec 31, 2022 | $16.32M | +8018.9% |
| Q3 FY2022 | Sep 30, 2022 | $7.49M | – |
| Q2 FY2022 | Jun 30, 2022 | -$7.37M | – |
| Q1 FY2022 | Mar 31, 2022 | -$13.96M | – |
| Q4 FY2021 | Dec 31, 2021 | $201.00K | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.49M | – |
| Q2 FY2021 | Jun 30, 2021 | -$11.78M | – |
| Q1 FY2021 | Mar 31, 2021 | -$11.72M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.71M | – |
| Q3 FY2020 | Sep 30, 2020 | -$10.12M | – |
| Q2 FY2020 | Jun 30, 2020 | -$25.63M | – |
| Q1 FY2020 | Mar 31, 2020 | -$15.03M | – |
| Q4 FY2019 | Dec 31, 2019 | -$6.52M | – |
| Q3 FY2019 | Sep 30, 2019 | -$4.01M | – |
| Q2 FY2019 | Jun 30, 2019 | -$13.84M | – |
| Q1 FY2019 | Mar 31, 2019 | -$11.22M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.78M | – |
| Q3 FY2018 | Sep 30, 2018 | -$3.55M | – |
| Q2 FY2018 | Jun 30, 2018 | -$6.19M | – |
| Q1 FY2018 | Mar 31, 2018 | -$6.43M | – |
| Q4 FY2017 | Dec 31, 2017 | -$3.34M | – |
| Q3 FY2017 | Sep 30, 2017 | -$3.25M | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.05M | – |
| Q1 FY2017 | Mar 31, 2017 | -$5.57M | – |
See a number that looks wrong?